Faculty, Staff and Student Publications
Publication Date
12-1-2022
Journal
Translational Lung Cancer Research
DOI
10.21037/tlcr-22-828
PMID
36636418
PMCID
PMC9830259
PubMedCentral® Posted Date
12-11-2022
PubMedCentral® Full Text Version
Post-print
Published Open-Access
yes
Recommended Citation
Nathaniel Deboever and Jianjun Zhang, "Neoadjuvant Chemo-Immunotherapy for Lung Cancer: How Much Is Too Much?" (2022). Faculty, Staff and Student Publications. 5214.
https://digitalcommons.library.tmc.edu/uthgsbs_docs/5214
Included in
Bioinformatics Commons, Biomedical Informatics Commons, Genetic Phenomena Commons, Medical Genetics Commons, Oncology Commons
Comments
This article has been corrected. See Transl Lung Cancer Res. 2023 Feb 20;12(2):393. See the article "Preoperative immunochemotherapy for locally advanced non-small cell lung cancer: an analysis of the clinical outcomes, optimal number of cycles, and peripheral immune markers" on page 2364.